ArticleClinical and experimental medicine2025

Reduced-dose donor lymphocyte infusion is a viable therapeutic strategy for Epstein-Barr virus-related post-transplant lymphoproliferative disease after hematopoietic stem cell transplantation: a single-center experience.

Dong Zhou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.